Sanctuary Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,264
Closed -$207K 2610
2025
Q4
$207K Buy
+1,264
New +$198K ﹤0.01% 2263
2025
Q1
Sell
-1,368
Closed -$229K 2402
2024
Q4
$229K Sell
1,368
-268
-16% -$38.4K ﹤0.01% 2164
2024
Q3
$233K Buy
+1,636
New +$235K ﹤0.01% 2154

Other funds holding RGEN

Sanctuary Advisors's RGEN Position: Q1 2026 in Review

Sanctuary Advisors sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,264 shares — an estimated $207K sold.

Sanctuary Advisors first reported a position in RGEN in Q3 2024 and held it in 3 quarters. The position peaked at $233K in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Sanctuary Advisors reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Sanctuary Advisors sold 1,264 Repligen shares in Q1 2026, an estimated $207K.
  • Sanctuary Advisors first reported a position in Repligen in Q3 2024 and held it in 3 quarters.
  • Sanctuary Advisors's Repligen position peaked at $233K in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.